Cargando…
1095. Investigation of Risk Factors Associated with Serious Bacterial, Viral and Invasive Fungal Infections in Hematologic Patients on Ibrutinib
BACKGROUND: Ibrutinib is a tyrosine kinase inhibitor used to treat hematologic malignancies that may increase the risk of serious infection including invasive fungal infections (IFI). In a study of 378 patients with hematologic malignancy on ibrutinib, serious infection and IFI occurred in 11% and 4...
Autores principales: | Holowka, Thomas, Cheung, Harry, Malinis, Maricar F, Perreault, Sarah, Isufi, Iris, Azar, Marwan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776795/ http://dx.doi.org/10.1093/ofid/ofaa439.1281 |
Ejemplares similares
-
1092. Increased Risk of Serious Infections in Mantle Cell Lymphoma Versus Other Hematologic Malignancies in Patients on Ibrutinib
por: Holowka, Thomas, et al.
Publicado: (2020) -
535. Evaluation of the BioFire Blood Culture Identification (BCID2) panel for transplant recipients with a bloodstream infection
por: Palacios, Carlo Foppiano, et al.
Publicado: (2022) -
1391. Latent Tuberculosis Screening Cascade in Liver Transplant Candidates: A Single, Transplant Center Experience
por: Medvedeva, Natalia, et al.
Publicado: (2019) -
Antiviral Treatment of Coronavirus Disease-2019 Pneumonia
por: Radcliffe, Christopher, et al.
Publicado: (2023) -
Diagnostic Testing of COVID-19 in Solid Organ Transplantation: Current Clinical Application and Future Strategies
por: Trubin, Paul A., et al.
Publicado: (2020)